Can sight Sciences (sght) stock really move this high?
Wall Street Analysts See a 68% Upside in Sight Sciences, Inc. (SGHT): Can the Stock Really Move This High? The mean of analysts' price targets for Sight Sciences, Inc. (SGHT) points to a 67.6% upside in the stock.
What are analysts'target prices for sight Sciences'shares?
5 Wall Street analysts have issued 1 year target prices for Sight Sciences' shares. Their forecasts range from $27.00 to $46.00. On average, they anticipate Sight Sciences' share price to reach $40.50 in the next twelve months. This suggests a possible upside of 154.2% from the stock's current price.
What is the upside for sight Sciences'stock?
5 Wall Street analysts have issued 1 year target prices for Sight Sciences' shares. Their forecasts range from $27. 00 to $46. 00. On average, they anticipate Sight Sciences' share price to reach $40. 50 in the next twelve months. This suggests a possible upside of 154. 2% from the stock's current price.
When did sight Sciences'lock-up period expire?
Sight Sciences trades on the NASDAQ under the ticker symbol "SGHT." When did the company's lock-up period expire? Sight Sciences' lock-up period expired on Tuesday, January 11th. Sight Sciences had issued 10,000,000 shares in its IPO on July 15th. The total size of the offering was $240,000,000 based on an initial share price of $24.00.
See more
Should I buy or sell Sight Sciences stock right now?
5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sight Sciences in the last twelve months. There are curr...
What is Sight Sciences' stock price forecast for 2022?
5 brokerages have issued 12 month price objectives for Sight Sciences' stock. Their forecasts range from $17.00 to $45.00. On average, they expect...
How has Sight Sciences' stock price performed in 2022?
Sight Sciences' stock was trading at $17.57 at the beginning of 2022. Since then, SGHT stock has decreased by 45.4% and is now trading at $9.60. V...
When is Sight Sciences' next earnings date?
Sight Sciences is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for Sigh...
How were Sight Sciences' earnings last quarter?
Sight Sciences, Inc. (NASDAQ:SGHT) announced its quarterly earnings data on Tuesday, May, 10th. The company reported ($0.49) earnings per share (EP...
What guidance has Sight Sciences issued on next quarter's earnings?
Sight Sciences issued an update on its FY 2022 earnings guidance on Tuesday, June, 7th. The company provided earnings per share (EPS) guidance of f...
Who are Sight Sciences' key executives?
Sight Sciences' management team includes the following people: Mr. Paul Badawi , Co-Founder, Pres, CEO & Director (Age 47, Pay $496.71k) Dr. Dav...
Who are some of Sight Sciences' key competitors?
Some companies that are related to Sight Sciences include PROCEPT BioRobotics (PRCT) , Beauty Health (SKIN) , AtriCure (ATRC) , Nevro (NVRO) ,...
When did Sight Sciences IPO?
(SGHT) raised $150 million in an initial public offering on Thursday, July 15th 2021. The company issued 6,980,000 shares at $20.00-$23.00 per share.
About Sight Sciences
Sight Sciences (NASDAQ:SGHT) Frequently Asked Questions
Sight Sciences Inc. is a medical device company. It focused on the development and commercialization of proprietary devises which target the underlying causes of prevalent eye diseases. Sight Sciences Inc. is based in MENLO PARK, Calif.
Sight Sciences Valuation & Funding
5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sight Sciences in the last twelve months. There are currently 5 buy ratings for the stock.
Sight Sciences Cap Table
This information is available in the PitchBook Platform. To explore Sight Sciences‘s full profile, request access.
Sight Sciences Comparisons
This information is available in the PitchBook Platform. To explore Sight Sciences‘s full profile, request access.
Sight Sciences Signals
itation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehende
Sight Sciences Investors
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Transparency is our policy. Learn how it impacts everything we do
This information is available in the PitchBook Platform. To explore Sight Sciences‘s full profile, request access.
How we make money
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
How we use your personal data
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.
How we approach editorial content
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
